Evidence for a gene influencing haematocrit on chromosome 6q23-24: Genomewide scan in the Framingham Heart Study

Journal of Medical Genetics

Volumn 42, Issue 1, 2005, Pages 75-79

  Lin, J P ^a   O'Donnell, C J ^b,c   Levy, D ^d   Cupples, L A ^e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1; CHROMOSOME 6Q; CHROMOSOME 9Q; CIGARETTE SMOKING; DIABETES MELLITUS; FEMALE; GENETIC LINKAGE; GENOME; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 6; GENETIC MARKERS; GENOME, HUMAN; HEART DISEASES; HEMATOCRIT; HUMANS; INCIDENCE; MASSACHUSETTS;

EID: 13244296993     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.021097     Document Type: Article

References (38)

1. Kannel WB, Gordon T, Wolf PA, McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham study. Stroke 1972;3:409-20.
2. Tohgi H, Yamanouchi H, Murakami M, Kameyama M. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 1978;9:369-74.
3. Giroud M, Creisson E, Fayolle H, Andre N, Becker F, Martin D, Dumas R. Rick factors for primary cerebral hemorrhage: a population-based study-the Stroke Registry of Dijon. Neuroepidemiology 1978;14:20-6.
4. Carter C, McGee D, Reed D, Yano K, Stemermann G. Hematocrit and the risk of coronary heart disease. Am Heart J 1983;105:674-9.
5. Gagnon DR, Zhang T-J, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 1994;127:674-82.
6. Lippi G, Manzato F, Franchini M, Guidi G. Relationship between hematocrit, primary hemostasis, and cardiovascular disease in athletes. Am Heart J 2002;144:14.
7. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. BMJ 1973;4:576-81.
8. Dormandy Jam Gutteridge JM, Hoare E, Dormandy TL Effect of clofibrate on blood viscosity in intermittent claudication. BMJ 1974;4:259-62.
9. Lowe GDO, Forbes CD. Blood rheology and thrombosis. Clin Haematol 1981;10:343-67.
10. Elwood PC, Waters WE, Benjamin IT, Sweetnam PM. Mortality and anaemia in women. Lancet 1974;1:891-4.
11. Sortie PD, Garcia-Palmieri MR, Costas R Jr, Havlik RJ, Juan S. Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program. Am Heart J 1974;101:456-61.
12. Wannamethee G, Perry IJ, Shaper AG. Hematocrit, hypertension and risk of stroke. J Intern Med 1994;235:163-8.
13. Ott EO, Lechner H, Aranibar A. High blood viscosity syndrome in cerebral infarction. Stroke 1974;5:330-3.
14. Whitfield JB, Martin NG. Genetic and environmental influences on the size and number of cells in the blood. Genet Epidemiol 1985;2:133-44.
15. Evans DM, Frazer IH, Martin NG. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res 1999;2:250-7.
16. Garner C, Mitchell J, Hatzis T, Reittie J, Farrall M, Thein SL. Haplotype mapping of a major quantitative-trait locus for fetal hemoglobin production, on chromosome 6q23. Am J Hum Genet 1998;62:1468-74.
17. Pravenec M, Zidek V, Zdobinska M, Kren V, Krenova D, Bottger A, van Zutphen LFM, Wang J-M, St Lezin E. Mapping genes controlling hematocrit in the spontaneously hypertensive rat. Mamm Genome 1997;8:387-9.
18. Dowber TR. The Framingham Heart Study: the epidemiology of atherosclerotic diseases. Cambridge, MA: Harvard University Press, 1980.
19. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families-The Framingham offspring study. Am J Epidemiol 1979;110:281-90.
20. Yuan B, Vaske D, Weber JL, Beck J, Sheffield VC. Improved set of short-tandem-repeat polymorphisms for screening the human genome. Am J Hum Genet 1997;60:459-60.
21. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:198-211.
22. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol 1997;14:959-64.
23. Almasy L, Dyer TD, Blangero J. Bivariate quantitative trait linkage analysis: Pleiotropy versus co-incident linkages. Genet Epidemiol 1997;14:953-8.
24. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:271-7.
25. Bliss CI. Statistics in biology, vol 1. New York: McGraw-Hill, 1967.
26. Parra M, Gascard P, Walensky LD, Snyder SH, Mohandas N, Conbay JG. Cloning and characterization of 4.1G (EPB41L2), a new member of the skeletal protein 4.1 (EPB41) gene family. Genomics 1998;49:298-306.
27. Craig JE, Rochette J, Fisher CA, Weatherall DL, Marc S, Lathrop GM, Demenais F, Thein S. Dissecting the loci controlling fetal haemoglobin production on chromosome 11p and 6q by the regressive approach. Nat Genet 1996;12:58-64.
28. Gamer C, Tatu T, Reittie JE, Littlewood T, Darley J, Cervino S, Farrall M, Kelly P, Spector TD, Thein SL. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000;95:342-6.
29. Lee-Huang S. Cloning and expression of human erythropoietin cDNA in Escherichia coli. Proc Natl Acad Sci USA 1984;81:2708-12.
30. Jones SS, D'Andrea AD, Haines LL, Wong GG. Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood 1990;76:31-5.
31. Deisseroth A, Nienhuis A, Turner P, Velez R, Anderson WF, Ruddle FH, Lawrence J, Creagan RP, Kucherlapati RS. Localization of the human alpha globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell 1977;12:205-18.
32. Deisseroth A, Nienhuis AW, Lawrence J, Giles RE, Turner P, Ruddle FH. Chromosomal localization of the human beta globin gene to human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci USA 1978;75:1456-60.
33. Huebner K, Palumbo AP, Isobe M, Kozak CA, Monaco S, Rovera G, Croce CM, Curtis PJ. The alpha-spectrin gene is on chromosome 1 in mouse and man. Proc Natl Acad Sci USA 1985;82:3790-3.
34. Prehal JT, Morley BJ, Yoon S-H, Coetzer TL, Palek J, Conboy JG, Kan YW. Isolation and characterization of cDNA clones for human erythrocyte beta-spectrin. Proc Natl Acad Sci USAi 1987;84:7468-72.
35. Tse WT, Menninger JC, Yang-Feng TL, Francke U, Sahr KE, Lux SE, Ward DC, Forget BG. Isolation and chromosomal localization of a novel non-erythroid ankyrin gene. Genomics 1991;10:858-66.
36. Showe LC, Ballantine M, Huebner K. Localization of the gene for the erythroid anion exchange protein, band 3 (EMPB3), to human chromosome 17. Genomics 1987;1:71-6.
37. Conboy J, Mohandas N, Tchernia G, Kan YW. Molecular basis of hereditary elliptocytosis due to protein 4.1 deficiency. New Engl J Med 1986;315:680-5.
38. Sung LA, Fan YS, Lambert K, Chien S, Lin C. Mapping of gene for human erythrocyte protein 4.2 to chromosomal region 15q15-q21. Cytogenet Cell Genet 1991;58:1996.